Hoʻopau kēia hopena i kahi kumu kumu o ka lāʻau lapaʻau: No nā maʻi maʻi bacteria a ʻaʻole kūpono nā lāʻau antibiotic i nā maʻi.
"ʻAʻole hana nā Antibiotics i nā maʻi maʻi, e like me nā mea e hoʻokumu ai i ke anu, ka maʻi maʻi, a i ʻole COVID-19," wahi a ka pūnaewele o ka US Centers for Disease Control and Prevention, e kākau ana "DO NOT" i nā leka nui i
Akā ʻo kahi hui o nā mea noiʻi, alakaʻi ʻia e Dr. Ragaey Ahmad Eid o ke Kulanui ʻo Beni-Suef, a me Kauka Marwa O. Elgendy o ke Kulanui ʻo Nahda, ʻelua ma Beni-Suef, ʻAigupita, ua ʻike i nā hihia i hoʻihoʻi maikaʻi ʻia nā antibiotics e mālama i ka viral. nā maʻi ma hope o ka hōʻike ʻia ʻana ua hiki iā lākou ke kāohi i hoʻokahi a ʻoi aku paha nā pae o ka pōʻaiapili o ka maʻi maʻi, hoʻomaha i nā hopena maikaʻi ʻole o ka maʻi maʻi, a i ʻole ka hoʻohana ʻana i ka ʻōnaehana pale e kōkua i ke kino e hoʻoponopono i ka maʻi.
No ka laʻana, ua ʻike ʻia kahi noiʻi ʻAmelika e pili ana i ʻelima mau makahiki i hala aku nei ua hiki i ka antibiotic azithromycin ke kaupalena i ka hana hou ʻana o ka maʻi Zika i loko o ka lolo o nā keiki i hānau ʻole ʻia, no laila hiki ke pale aku i ka microcephaly, ka mea i hana ʻia e ka maʻi i nā keiki hānau hou.
Ma ka noiʻi kaʻawale, ua hōʻike ʻia ka antibiotic novobiocin i kahi hopena antiviral ikaika e kūʻē i ka maʻi Zika.
A ua hōʻike ʻia kahi noiʻi 2016 ma Thailand e hiki ke hoʻohana ʻia ka minocycline antibiotic e pale i ka hana hou ʻana o ka maʻi dengue.
Ua hōʻike mua ʻia ka hoʻāʻo ʻana i kahi hoʻonohonoho lab i kahi papa o nā lāʻau i kapa ʻia ʻo beta-lactams hiki ke hoʻopilikia i ka hoʻopiʻi ʻana o ka coronavirus. Ua hōʻike ʻia nā hoʻohālikelike kamepiula ʻelua beta-lactams - ceftazidime a me cefepime - i mea maikaʻi i ka hoʻopau ʻana i ka protease (Mno), he enzyme koʻikoʻi e hoʻohana ai ka maʻi e hana hou.
ʻO ka noiʻi lapaʻau, i mālama ʻia ma ke keʻena kaʻawale o ka Halemai ʻo Beni-Suef University mai Malaki 15 a Mei 20, 2021, hoʻohālikelike i nā hopena o nā mea maʻi me nā maʻi maʻamau a koʻikoʻi o COVID-19 i hāʻawi ʻia i ka mālama maʻamau (110 mau maʻi) me ka nā hopena o nā maʻi maʻi COVID i hāʻawi ʻia i kekahi o nā beta-lactams - a i ʻole ceftazidime (136 mau mea maʻi) a i ʻole cefepime (124 mau maʻi) - me ka steroid dexamethasone.
ʻO kēia lapaʻau maʻamau no COVID-19, i ʻae ʻia e ka World Health Organization a me ke aupuni o ʻAigupita, aia ma kahi o ʻehiku mau lāʻau lapaʻau like ʻole.
ʻO ka manawa hoʻōla no nā maʻi i hāʻawi ʻia i ka lāʻau maʻamau he 19 mau lā. ʻO ka manawa hoʻōla no ka poʻe i hāʻawi ʻia i ka ceftazidime he 13 lā a no ka poʻe i hāʻawi ʻia i ka cefepime he 12 lā. ʻAʻohe make a ua ola nā maʻi a pau me ka pilikia ʻole.
ʻAʻole maopopo i ka nui o ka pono o nā lāʻau antibiotic i hiki ke hoʻopili ʻia i ko lākou pono i ka hoʻomaʻemaʻe ʻana i nā coinfections, e like me ka maʻi pneumonia, nā mea maʻi COVID e ulu pinepine ai, a pehea ka nui o ka hoʻouka ʻana i ka hiki o ka maʻi ke hana hou.
Eia naʻe, hoʻopau nā mea noiʻi i kā lākou ʻatikala ma ke aʻo ʻana, i paʻi ʻia ma ka puke pai Antibiotics i ʻOkakopa 2021, "hiki i ka ceftazidime a i ʻole cefepime ke hāʻawi i nā mea maʻi COVID-19 i nā pōmaikaʻi hou aku, ʻo ia nā mea antiviral maikaʻi ma waho aʻe o kā lākou waiwai antibacterial koʻikoʻi," a ʻōlelo ʻo ka hoʻohana ʻana i kekahi o kēia mau beta-lactams, i hui pū ʻia me nā steroids, e mālama i ka maʻalahi. a hiki i nā hihia koʻikoʻi COVID-19 ke hana i "nā hopena maikaʻi aʻe me nā hopena ʻaoʻao liʻiliʻi, ma kahi o ka protocol lapaʻau multidrug paʻakikī i kēia manawa."
Source: Steven Ganot, themedialine.org
He aha e lawe ʻia mai kēia ʻatikala:
- Elgendy of Nahda University, both in Beni-Suef, Egypt, knew of cases in which antibiotics were successfully repurposed to treat viral infections after it was shown that they were able to inhibit one or more stages of the virus's replication cycle, relieve the bad effects of the virus, or manipulate the immune system to help the body deal with the virus.
- ʻO ka noiʻi lapaʻau, i mālama ʻia ma ke keʻena kaʻawale o ka Halemai ʻo Beni-Suef University mai Malaki 15 a Mei 20, 2021, hoʻohālikelike i nā hopena o nā mea maʻi me nā maʻi maʻamau a koʻikoʻi o COVID-19 i hāʻawi ʻia i ka mālama maʻamau (110 mau maʻi) me ka nā hopena o nā maʻi maʻi COVID i hāʻawi ʻia i kekahi o nā beta-lactams - a i ʻole ceftazidime (136 mau mea maʻi) a i ʻole cefepime (124 mau maʻi) - me ka steroid dexamethasone.
- Nevertheless, the researchers conclude in their article on the study, published in the journal Antibiotics in October 2021, that “ceftazidime or cefepime can currently provide COVID-19 patients extra benefits, being good antiviral agents besides their outstanding antibacterial properties,” and say that the use of either of these beta-lactams, combined with steroids, to manage moderate and severe COVID-19 cases can produce “better outcomes with minor side effects, instead of the currently used complex multidrug treatment protocol.
